ASH-ASTCT-BMT CTN-CIBMTR-NMDP Submit Letter to CMS on National Coverage Decision for HSCT FOR MDS
Citations
American Society of Hematology. (2024).
ASH-ASTCT-BMT CTN-CIBMTR-NMDP Submit Letter to CMS on National Coverage Decision for HSCT FOR MDS.
Retrieved from https://www.hematology.org/advocacy/policy-news-statements-testimony-and-correspondence/testimony-and-correspondence/ash-astct-bmt-ctn-cibmtr-nmdp-submit-letter-to-cms-on-national-coverage-decision-for-hsct-for-mds.
American Society of Hematology.
"ASH-ASTCT-BMT CTN-CIBMTR-NMDP Submit Letter to CMS on National Coverage Decision for HSCT FOR MDS." Hematology.org.
https://www.hematology.org/advocacy/policy-news-statements-testimony-and-correspondence/testimony-and-correspondence/ash-astct-bmt-ctn-cibmtr-nmdp-submit-letter-to-cms-on-national-coverage-decision-for-hsct-for-mds
(label-accessed February 12, 2025).
"American Society of Hematology."
ASH-ASTCT-BMT CTN-CIBMTR-NMDP Submit Letter to CMS on National Coverage Decision for HSCT FOR MDS, 12 Feb. 2025 ,
https://www.hematology.org/advocacy/policy-news-statements-testimony-and-correspondence/testimony-and-correspondence/ash-astct-bmt-ctn-cibmtr-nmdp-submit-letter-to-cms-on-national-coverage-decision-for-hsct-for-mds.